5432752025-04-012025-06-305432752025-04-012025-06-30in-capmkt:OtherExpenses1Member5432752025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15432752025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25432752025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15432752025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares543275ANURASNOTLISTEDINE930P01018ANUPAM RASAYAN INDIA LIMITEDMain BoardEquity2025-04-012026-03-312025-08-132025-08-08INRMillionsQuarterlyFirst quarterSingle segmentManufacturing of Industrial Chemicals2025-08-1317:34:002025-08-1317:58:00Not applicable2025-04-012025-06-30UnauditedConsolidated4858270000491200004907390000361202000019580000-1193030000203310000356650000306820000973540000427889000062850000006285000001177300002619000014392000004845800000000484580000-81900004763900003403600001442200003321700001442200001099310000103.13.1003.13.11 The above Consolidated financial results for the quarter ended June 30 2025 have been prepared by the Company in accordance with Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended and were reviewed by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their meeting held on August 13 2025. <BR> <BR> 2 Based on the management approach as defined in Ind AS 108 Operating Segments the Chief Operating Decision Maker CODM evaluates the companys performance and allocates resources based on the analysis of various performance indicators of business segments in which the company operates. The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence disclosure of segment wise information is not required and accordingly not provided. <BR> <BR> 3 Subsequent to the quarter end the Holding Company has declared and paid an interim dividend for Financial Year 2024 25 of INR 0.75 Rupees per equity share of face value of INR 10 Rupees each. <BR> <BR> 4 The Company has investment in the following subsidiary companies and an associate company as on June 30 2025 and accordingly consolidated financial results for the quarter ended June 30 2025 includes following entities <BR> <BR> Name of the Subsidiary Nature of relationship <BR> a Jainam Intermediates Private Limited Wholly owned subsidiary <BR> b Tanfac Industries Limited Subsidiary Company over which the Company exercises effective control <BR> c ARIL Transmodal Logistic Private Limited Wholly owned subsidiary <BR> d ARIL Fluorospeciality Private Limited Wholly owned subsidiary <BR> e Anupam Japan GK Wholly owned subsidiary <BR> f Anupam Europe AG Wholly owned subsidiary <BR> g Anupam USA LLC Wholly owned subsidiary <BR> h Anupam General Trading FZE Wholly owned subsidiary <BR> i Tangent Science Private Limited An associate Company of wholly owned subsidiary of the Company <BR> <BR> 5 The figures of the previous period have been re grouped rearranged and or recasted wherever considered necessary. The figures of the last quarter as reported are the balancing figures between audited figures in respect of the full financial year ended March 31 2025 and the published unaudited year to date figures up to third quarter of the previous financial year end and the figures upto the end of the third quarter had only been reviewed and not subject to audit. Other Expenses973540000Gain/(loss) on remeasurements of the defined benefits plan-17630000Income tax (expense)/income on remeasurements of the defined benefits plan6160000-114700000Effective portion of gain/(loss) on hedging instruments in a cash flow hedge4910000Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge-163000032800000-8190000